News Focus
News Focus
Post# of 257295
Next 10
Followers 15
Posts 763
Boards Moderated 0
Alias Born 12/09/2013

Re: mcbio post# 206098

Wednesday, 11/16/2016 9:13:10 AM

Wednesday, November 16, 2016 9:13:10 AM

Post# of 257295

And is there some specific reason as to why ENTA-based regimen works in this specific population where SOF does not?



I don't think it is Enanta per se.

I think it is about where drugs are metabolized; Sovaldi places more burden on the kidneys. I think/thought Harvoni was still effective, it was just too rough on the kidneys for some patients.

https://www.drugs.com/pro/sovaldi.html

"Severe Renal Impairment and End Stage Renal Disease

No dosage recommendation can be given for patients with severe renal impairment (estimated Glomerular Filtration Rate [eGFR] less than 30 mL/min/1.73m2) or with end stage renal disease (ESRD) due to higher exposures (up to 20-fold) of the predominant sofosbuvir metabolite."

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today